Andujar, Quiel Timothy C.

HRN: 22-50-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
CEFTRIAXONE 1G (VIAL)
01/28/2023
02/04/2023
IVT
625 Mg
12 Hrs
T/c Typhoid Fever
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: